✦ LIBER ✦

1BA Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

✍ Scribed by C. Manegold; R. Digumarti; M. Zukin; F. de Marinis; A. Mellemgaard; D. Gandara; L. Simms; C. Kaiser; J. Blatter; U. Gatzemeier

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival without toxicity for cisplatin

✍ Giorgio V. Scagliotti; Keunchil Park; Shekar Patil; Janusz Rolski; Tuncay Goksel 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 236 KB

Randomized phase II study of gemcitabine

✍ Kim, Jee Hyun; Kim, Si Young; Jung, Kyung Hae; Park, Keunchil; Suh, Cheol Won; L 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Randomized, multicenter, phase II study

✍ Mazzanti, Paola; Massacesi, Cristian; Rocchi, Marco B.L.; Mattioli, Rodolfo; Lip 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 216 KB

A prospective, multicentre clinical tria

✍ Tuncay GOKSEL; Osman Nuri HATIPOGLU; Can OZTURK; Metin GORGUNER; Murat KIYIK; Ug 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Clinical observation of docetaxel plus c

✍ Yongguang Cai; Ming Li; Xin Xie 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 216 KB

Phase II trial of gemcitabine plus cispl

✍ Yu, Hai-feng; Wu, Feng-qin; Fan, Yun; Lin, Neng-ming; Ma, Sheng-lin; Luo, Lü-hon 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 Chinese ⚖ 317 KB